Webb4 apr. 2024 · Among all patients, 1,113 were discharged on the day of the procedure (597 in 2024 and 516 in 2024). Of 516 transfemoral TAVR patients in 2024, 114 patients (22.1%) were discharged the same day vs. 329 patients (63.8%) on the next day. There were no deaths among those with a same-day discharge vs. three deaths in those discharged the … WebbIn addition to the main findings, we envision more than 20 Substudies including coronary access (4000 baseline core lab CT scans and 6000 core lab angiograms), antithrombotic therapies, stenosis severity, lesion location, intracoronary imaging, CT FFR, QOL, and cost effectiveness. 2.
PROTECTED TAVR Study - Boston Scientific
Webb17 sep. 2024 · Sep 17, 2024. Use of a cerebral embolic protection (CEP) device may be effective at capturing debris in patients undergoing transcatheter aortic valve replacement (TAVR) for aortic stenosis, but it did not reduce the risk of stroke in the PROTECTED TAVR trial. A 3000-patient trial conducted across North America, Europe, and Australia, results ... WebbThe PROTECTED TAVR Study is the largest randomized TAVR trial to date with 3,000 patients enrolled at more than 50 global sites who were randomized 1:1 – patients … how many draft picks the philadelphia eagles
Same-Day Discharge Post-Transcatheter Aortic Valve …
Transcatheter aortic valve replacement (TAVR) for patients with severe aortic stenosis has matured into a standardized procedure with high degrees of procedural success and safety. However, certain risks and adverse events remain, deserving specific attention, especially, as TAVR expands towards lower-risk … Visa mer A total of 3,000 patients from 51 sites were 1:1 randomized to either TAVR with (n = 1,501) or without CEP (n = 1,499). All TAVR procedures were performed transfemorally with commercially available devices (64% Sapien 3 … Visa mer Mean age of the trial population was 78.9 years, 42% of CEP patients were female, while only 38% of the control patients were female, and mean STS score was 3.4% (well-balanced with … Visa mer The eagerly awaited PROTECTED TAVR trial will undoubtedly have an important impact on the field of CEP. Despite the concept’s intriguing logic, previous studies failed to show a … Visa mer Webb24 mars 2024 · In the multicenter prospective PROTECT TAVR study, the overall composite adverse event rate at 30 days was low at 5.7% and all 124 low-risk patients, including one who required a permanent ... Webb17 mars 2024 · SENTINEL™ CPS is a cerebral embolic protection device that captures and removes debris dislodged during #TAVR procedures. New data from the #PROTECTEDTAVR Study, an all-comers study with 3,000 ... high tide spurn point today